TP53BP2
protein-codingtumor protein p53 binding protein 2, the group of Protein phosphatase 1 regulatory subunits|Ankyrin repeat domain containing
Gene summary
This gene encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. The protein contains four ankyrin repeats and an SH3 domain involved in protein-protein interactions. It is localized to the perinuclear region of the cytoplasm, and regulates apoptosis and cell growth through interactions with other regulatory molecules including members of the p53 family. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~66.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0007661
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0005338
Submitter: ClinGen
*TP53BP2* was first reported in relation to autosomal dominant primary open angle glaucoma in 2018 (Michale, et al., PMID: 28150229). Primary open angle glaucoma is characterized by a loss of retinal ganglion cells, visual field defects, and cupping of the optic disc. This curation includes one missense variant reported in one proband in one publication (PMID: 28150229). This proband was also reported to have a variant in the *MAPKAPK2* gene, and group members were therefore unable to conclusively confirm the cause of the phenotype within this proband. This gene-disease association is not supported by any experimental evidence. The *TP53BP2* gene is expressed in the human cornea (PMID: 11709013), and its gene product reportedly interacts with components of apoptosis pathways and may regulate cell cycle progression (PMID: 8668206), but the relevance of this evidence to primary open-angle glaucoma is not yet clear. In summary, the gene-disease relationship between *TP53BP2* and primary open angle glaucoma is classified as disputed. This classification was approved by the ClinGen Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel on May 18th, 2023.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TP53BP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001031685.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 6 | 8 | 16 | ||
| missense | 143 | 8 | 3 | 154 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 150 | 14 | 11 | 175 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001026855.2 | 18 | MANE Select | |
| Ensembl | ENSP00000341957.7 | 18 | MANE Select | |
| RefSeq | NP_005417.1 | 14 | Standard | |
| Ensembl | ENSP00000375750.2 | 14 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tp53bp2b | Danio rerio | Structure: otolith Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Hippo signaling pathway - Homo sapiens (human)
- Gene expression (Transcription)
- Generic Transcription Pathway
- TP53 Regulates Transcription of Cell Death Genes
- RNA Polymerase II Transcription
Biological Process
- cell cycle
- signal transduction
- regulation of apoptotic process
- negative regulation of cell cycle
- intrinsic apoptotic signaling pathway by p53 class mediator
Molecular Function
- p53 binding
- SH3/SH2 adaptor activity
- protein binding
- SH3 domain binding
- identical protein binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000343537
- Coding exons
- 18
- Length
- 66074
- Individuals with no LoFs
- 125711
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 37
- Defined
- 125748
- p
- 0.000147
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.89 | 498 | 632 | 0.788 | 0.0000356 | 7420 |
| Missense (PolyPhen) | 188 | 283.29 | 0.66364 | 3220 | ||
| Synonymous | 0.400 | 226 | 234 | 0.967 | 0.0000138 | 2186 |
| Loss of Function | 4.96 | 16 | 56.1 | 0.285 | 0.00000292 | 647 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00021 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00012 | 0.000099 | rare |
| East Asian | 0.00017 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions. Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of APPBP1 to conjugate NEDD8 to CUL1, and thereby decreases APPBP1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42. {ECO:0000269|PubMed:11684014, ECO:0000269|PubMed:12694406, ECO:0000269|PubMed:19377511}.;
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- LoFtool
- 0.758
- RVIS EVS
- -1.13
- RVIS percentile EVS
- 6.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.816
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |